FDA Inspection
SNF Holdings, LLC dba Vios CompoundingSNF Holdings, LLC dba Vios Compounding – FDA Inspection, Mar 2, 2023
Record Details
This FDA Inspection record concerns SNF Holdings, LLC dba Vios Compounding, with an inspection on March 2, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 92606db8-5e70-475b-bdac-31f544b3034f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1201524
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- State Referral Letter
FDA Citations
5- Non-microbial contamination, production area
- Hazardous drugs, prevention of cross-contamination
- Use of non-pharmaceutical grade components
- FDCA 501(a)(2)(A)Non-microbial contamination, production area
- FDCA 501(a)(2)(A)Use of non-pharmaceutical grade components
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.